Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Accumulated Depreciation & Amortization (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $704246.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 31.33% to $704246.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $704246.0 through Dec 2025, up 31.33% year-over-year, with the annual reading at $704246.0 for FY2025, 31.33% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $704246.0 at bioAffinity Technologies, up from $666717.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $704246.0 in Q4 2025, with the low at $2900.0 in Q3 2022.
  • Average Accumulated Depreciation & Amortization over 4 years is $432521.6, with a median of $432852.0 recorded in 2024.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 11484.83% in 2023, then soared 31.33% in 2025.
  • Over 4 years, Accumulated Depreciation & Amortization stood at $269180.0 in 2022, then skyrocketed by 38.61% to $373123.0 in 2023, then surged by 43.72% to $536251.0 in 2024, then skyrocketed by 31.33% to $704246.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $704246.0, $666717.0, and $624481.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.